Par cuts workforce 30% and restructures generics division
US drugmaker Par Pharmaceuticals is wielding the axe at its generics division, cutting 190 jobs and refocusing its R&D efforts on the completion of its current roster of product candidates
Archives for October 14, 2008
House probes FDA over Actavis recalls
A new avenue of inquiry has been opened in the investigation into the US Food and Drug Administration’s (FDA) ability and commitment to protect the nation’s citizens from unsafe drugs.
Counterfeiters can get life in jail under new US Act
US President George W Bush has signed a bill under which counterfeiters can be sentenced to life imprisonment if their crime causes the death of an individual.